Industry: Pharmaceuticals, Biotechnology
Ambrx, Inc., is a biopharmaceutical company focused on optimizing existing protein drugs. Using its patented technology, the company can overcome the performance challenges of high-value commercial proteins by improving their efficacy, safety and ease of use. Ambrx’s core ReCODE technology allows for the precise, site-specific substitution of a novel amino acid within a protein. This technology is applicable to multiple protein products across numerous therapeutic areas. Ambrx expects to initiate clinical trials with a long-acting, PEGylated human growth hormone in early 2007, followed by an enhanced, PEGylated interferon alpha molecule. With its innovative approach, Ambrx has successfully bridged the gap between a platform that works and drug development. ( www.ambrx.com )
Ambrx , Inc.
10975 North Torrey Pines Road
La Jolla, California 92037
USA
Tel: (858) 875-2400
Fax: (858) 453-9511